At Pharmageddon, we reject the very notion of a ‘speaker circuit’.
We’re here to gather the renegades, the disruptors, the unapologetic rebels; those who challenge the status quo. The conversations that happen here won’t echo mainstream topics and aren’t repeated anywhere else.
Mark Montgomery Vice President and International Head, Integrated Insights Novartis
Harsha Shetty Sr Director, Global Safety, Patient Engagement and Sustainability Lead CSL Behring
Alex Condoleon Chief Medical Affairs Officer of Medical Engagements & Impact Pfizer
April Kelly US Head of Market Development, Type 1 Diabetes Sanofi
Camille Hertzka VP, Global Medical Affairs Solid Tumors Johnson and Johnson
Marilyn Metcalf Global Vaccines Lead for Patient Engagement GSK
Jose Maria (Chema) Guido Avila Global Dupixent Patient Experience Lead Respiratory Sanofi
Luca Dezzani Vice President, US Medical Affairs BioNtech
Justin Molavi Director, Commerical Strategy and Insights Genentech
Kieran Davey Senior Global Medical Affairs Leader, Lung Cancer AstraZeneca
Anthony Yanni Senior Vice President and Global Head of Patient Centricity Astellas
Jill Donahue CEO Excellerate
Sebastian Sorsaburu Therapeutic Area Head, US Medical Affairs CSL Behring
Joseph Michael Burns Sr Director, Customer Experience Tech Eli Lilly and Company
Richie Etwaru CEO Mobeus
Nancy Borowick Photo Journalist
Guru Banavar Founding CTO Viome
Izabela Lundberg CEO Legacy Leaders Institute
Daniel Mullins Professor and Executive Director The PATIENTS Program, University of Maryland School of Pharmacy
Damion Nero Head of Data Science Takeda
Tom Croce Vice President, Global Patient Advocacy Jazz Pharmaceuticals
Ann Hartry Assoc Vice President, Value, Evidence, & Outcomes, Neuroscience Eli Lilly
Paul Simms Chief Executive Impatient Health Read more
Anna Rathkopf Co-Founder The Rathkopfs
Jordan Rathkopf Co-Founder The Rathkopfs
Email Lucy Osborne at [email protected]